Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 448 followers

Latest posts

Last updated about 14 hours ago

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 19, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation...

Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date of authorisation: 18/09/2026, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Ruxolitinib Viatris, ruxolitinib hemifumarate, Date...

PSUSA/00010431/202510

about 14 hours ago

PSUSA/00010431/202510

Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Date of authorisation: 21/09/2026, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Nezglyal, leriglitazone, Date of authorisation...

Human medicines European public assessment report (EPAR): Jorveza, budesonide, Date of authorisation: 08/01/2018, Revision: 8, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Jorveza, budesonide, Date of authorisation...

Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 10, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of...

Article 57 product data

about 15 hours ago

Article 57 product data

Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Date of authorisation: 01/07/2008, Revision: 22, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Relistor, methylnaltrexone bromide, Date of...

Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Degevma, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 22, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan)...

Human medicines European public assessment report (EPAR): Givlaari, givosiran, Date of authorisation: 02/03/2020, Revision: 8, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Givlaari, givosiran, Date of authorisation...

Sponsor guidance: New safety module on the annual safety report

about 17 hours ago

Sponsor guidance: New safety module on the annual safety report